-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Olverembatinib in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Olverembatinib in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Olverembatinib in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ZX-7101A
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ZX-7101A Drug Details ZX-7101A is under development for the treatment of influenza virus A...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ZX-4081
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ZX-4081 Drug Details ZX-4081 is under development for the treatment of solid tumors including...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ZX-101A
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ZX-101A Drug Details ZX-101A is under development for the treatment of advanced solid tumors,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ZX-007
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ZX-007 Drug Details ZX-007Â is under development for the treatment of pain. It is administered...
-
Product Insights
Net Present Value Model: Fintepla
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Fintepla Drug Details Fenfluramine hydrochloride (Fintepla)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – fenfluramine hydrochloride
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry fenfluramine hydrochloride Drug Details Fenfluramine hydrochloride (Fintepla) is an amphetamine derivative a sympathomimetic stimulant....
-
Sector Analysis
PharmaPoint: Epilepsy – Global Drug Forecast and Market Analysis to 2026
Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. Seizures result from abnormal electrical discharges in the brain and vary in their manifestations, from the brief staring spells that are characteristic of absence seizures, to full-body convulsions known as tonic-clonic seizure. Epilepsy can be considered a spectrum disorder due to its different causes, different seizure types, and different disease severities. There are several anti-epileptic drugs (AEDs) on the market, with an older generation fully genericized across the...